June 05, 2024

Do Neighborhood Factors Play a Role in Lung Cancer Aggressiveness?

Investigators have examined whether neighborhood violence may be associated with aggressive lung cancer in Black men, according to new findings presented at the Endocrine Society’s Annual Meeting & Exposition 2024.

Conexiant

April 10, 2025

Insomnia, Short Sleep Raise Teen BP

New research links insomnia and short sleep duration to significantly increased risk of high blood pressure in adolescents.

Conexiant

June 04, 2025

Does Sleep Duration Shape Oral Microbiomes?

New research reveals positive association between extended sleep duration and higher oral microbiome diversity in adolescents and young adults.

Conexiant

May 19, 2025

Join Roswell Park Experts at ASCO

Nearly two dozen experts from Roswell Park Comprehensive Cancer Center will be attending this year’s American Society of Clinical Oncology conference in Chicago, May 30-June 3, and we’d like to invite you to meet them.

Roswell Park Comprehensive Cancer Center

April 07, 2025

Pulse Oximeter Bias in ICU Patients?

Pulse oximetry may be unreliable in diverse patient populations.

Conexiant

August 30, 2024

Quit Smoking, Halve Heart Attack Risk: Study

Quitting smoking post-CAD diagnosis cut risk of major cardiovascular events by 44% in international study of over 32,000 patients.

Conexiant

June 07, 2024

Study Identifies Subset of Patients With Lung Adenocarcinoma Who Have HER2 Alterations

Researchers have found that a proportion of patients with NSCLC and KRAS, EGFR, or ALK gene mutations may also have HER2 alterations, according to findings presented at the 2024 ASCO Annual Meeting.

The ASCO Post

October 29, 2024

Early AKI Intervention Fails to Improve Outcomes

Despite achieving a 33.8% implementation rate of its recommendations versus 24.3% in usual care, a novel kidney action team intervention failed to improve outcomes in 4,003 hospitalized patients with acute kidney injury - highlighting the complex challenge of translating increased diagnostic testing into better clinical results.

Conexiant

June 03, 2025

FDA Grants Breakthrough Status to Shield Test

The methylation-based blood assay is designed for screening multiple cancer types.

Conexiant